Table 3 Prevalence OR^# of musculoskeletal complaints (MSCs) related to fasting serum glucose, HbA1c and duration of the disease in patients with DM

Serum glucose

≤6.3 mmol/l

482

59.3

1.0 (reference)

6.4

1.0 (reference)

52.9

1.0 (reference)

6.4–8.7 mmol/l

487

55.2

0.8 (0.6–1.1)

5.1

0.7 (0.4–1.2)

50.1

0.8 (0.6–1.1)

8.8–12.1 mmol/l

472

54.9

0.8 (0.6–1.1)

6.1

0.8 (0.5–1.4)

48.7

0.8 (0.6–1.1)

≥12.2 mmol/l

469

57.4

1.0 (0.7–1.3)

6.4

1.0 (0.6–1.8)

51.0

1.0 (0.7–1.3)

Missing

30

70.0

1.2 (0.5–3.0)

0.0

-

70.0

1.5 (0.6–3.6)

HbA1c

≤6.8 mmol/l

509

57.2

1.0 (reference)

6.7

1.0 (reference)

50.5

1.0 (reference)

6.9–7.8 mmol/l

422

59.2

1.1 (0.9–1.5)

5.0

0.8 (0.4–1.5)

54.3

1.2 (0.9–1.5)

7.9–9.2 mmol/l

481

55.7

1.0 (0.7–1.2)

5.2

0.8 (0.5–1.4)

50.5

1.0 (0.8–1.3)

≥9.3 mmol/l

426

53.8

0.9 (0.7–1.2)

7.0

1.0 (0.6–1.7)

46.7

0.9 (0.7–1.2)

Missing

102

64.7

1.4 (0.9–2.1)

4.9

0.8 (0.3–2.4)

59.8

1.4 (0.9–2.3)

Duration of DM

≤2 years

502

56.2

1.0 (reference)

6.4

1.0 (reference)

49.8

1.0 (reference)

3–6 years

360

56.4

1.0 (0.8–1.4)

4.7

0.8 (0.4–1.4)

51.7

1.1 (0.8–1.4)

7–13 years

403

57.1

1.1 (0.8–1.4)

6.0

1.1 (0.6–2.1)

51.1

1.1 (0.8–1.5)

≥14 years

406

59.1

1.2 (0.9–1.6)

6.9

1.6 (0.9–2.8)

52.2

1.2 (0.9–1.6)

Missing

269

55.4

1.0 (0.7–1.3)

5.2

1.0 (0.5–2.1)

50.2

1.0 (0.7–1.3)